Pathometagenomics reveals susceptibility to intestinal infection by Morganella to be mediated by the blood group-related B4galnt2 gene in wild mice

Gut Microbes. 2023 Jan-Dec;15(1):2164448. doi: 10.1080/19490976.2022.2164448.

Abstract

Infectious disease is widely considered to be a major driver of evolution. A preponderance of signatures of balancing selection at blood group-related genes is thought to be driven by inherent trade-offs in susceptibility to disease. B4galnt2 is subject to long-term balancing selection in house mice, where two divergent allele classes direct alternative tissue-specific expression of a glycosyltransferase in the intestine versus blood vessels. The blood vessel allele class leads to prolonged bleeding times similar to von Willebrand disease in humans, yet has been maintained for millions of years. Based on in vivo functional studies in inbred lab strains, it is hypothesized that the cost of prolonged bleeding times may be offset by an evolutionary trade-off involving susceptibility to a yet unknown pathogen(s). To identify candidate pathogens for which resistance could be mediated by B4galnt2 genotype, we here employed a novel "pathometagenomic" approach in a wild mouse population, which combines bacterial 16S rRNA gene-based community profiling with histopathology of gut tissue. Through subsequent isolation, genome sequencing and controlled experiments in lab mice, we show that the presence of the blood vessel allele is associated with resistance to a newly identified subspecies of Morganella morganii, a clinically important opportunistic pathogen. Given the increasing importance of zoonotic events, the approach outlined here may find useful application in the detection of emerging diseases in wild animal populations.

Keywords: B4galnt2; Morganella; balancing selection; blood group; enteric infection; gut microbiome; wild mice.

MeSH terms

  • Animals
  • Blood Group Antigens*
  • Gastrointestinal Microbiome*
  • Genotype
  • Humans
  • Mice
  • Morganella
  • RNA, Ribosomal, 16S

Substances

  • Blood Group Antigens
  • RNA, Ribosomal, 16S

Grants and funding

The authors acknowledge funding provided by the Deutsche Forschungsgemeinschaft (DFG) to JFB (EXC 22167-390884018, RU 1078, CRC 1182 - Project Z3) and GAG (CRC 900 TP8 - Project number 158989968, SPP 1656/1, SPP 1656/2), as well as funding by the International Max Planck Research School (IMPRS) in Evolutionary Biology to JFB.